Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Rohit Gupta & Merlin Ariefdjohan. (2021) Mental illness on Instagram: a mixed method study to characterize public content, sentiments, and trends of antidepressant use. Journal of Mental Health 30:4, pages 518-525.
Read now
Read now
Articles from other publishers (20)
Jane C. J. Spragg, Toni J. F. Michael, Parisa Aslani, Matthew J. Coleshill, Jian S. Chan, Richard O. Day & Sophie L. Stocker. (2023) Optimizing adherence to allopurinol for gout: patients' perspectives. British Journal of Clinical Pharmacology 89:7, pages 1978-1991.
Crossref
Crossref
Ana María Téllez-López, Isis Beatriz Bermudez-Camps, Ivette Reyes-Hernández, Claudia Fegadolli & Leobardo Manuel Gómez-Oliván. (2023) Methodological - Theoretical approach to phenomenological studies on the experience of medication use: A systematic review. Research in Social and Administrative Pharmacy 19:6, pages 845-858.
Crossref
Crossref
Henry N. Young, Farah S. Pathan, Stan Hudson, David Mott, Paul D. Smith & Kenneth G. Schellhase. (2023) Impact of patient-centered prescription medication labels on adherence in community pharmacy. Journal of the American Pharmacists Association 63:3, pages 785-792.
Crossref
Crossref
Nazar Muhammad, Salecah R Ullah, Talwinder K Nagi & Rao Ahmed Yousaf. (2023) Factors Associated With Non-adherence to Anti-depressant Medication in Adults: A Systematic Review and Meta-Analysis. Cureus.
Crossref
Crossref
Esther J. Holmes, Subhash Aryal & Scott T. Walters. (2021) What lifestyle factors predict depressive symptoms? A longitudinal assessment among permanent supportive housing residents. Journal of Public Health 31:4, pages 591-601.
Crossref
Crossref
Alba Sánchez-Viñas, Carmen Corral-Partearroyo, Montserrat Gil-Girbau, M. Teresa Peñarrubia-María, Carmen Gallardo-González, María-del-Carmen Olmos-Palenzuela, Ignacio Aznar-Lou, Antoni Serrano-Blanco & Maria Rubio-Valera. (2022) Effectiveness and cost-effectiveness of an intervention to improve Initial Medication Adherence to treatments for cardiovascular diseases and diabetes in primary care: study protocol for a pragmatic cluster randomised controlled trial and economic model (the IMA-cRCT study). BMC Primary Care 23:1.
Crossref
Crossref
Keren Nitzan, Matthew O. Parker, Alon Shamir, Gang Chen & Ravid Doron. (2022) Editorial: The burden of stress and depression – new insight into faster and efficient treatment. Frontiers in Behavioral Neuroscience 16.
Crossref
Crossref
Muhammad Umair Khan, Camila Balbontin, Michiel C. J. Bliemer & Parisa Aslani. (2022) Eliciting preferences for continuing medication among adult patients and parents of children with attention‐deficit hyperactivity disorder. Health Expectations 25:3, pages 1094-1107.
Crossref
Crossref
Maria Teresa Peñarrubia‐María, Montserrat Gil‐Girbau, Mari Carmen Gallardo‐González, Ignacio Aznar‐Lou, Antoni Serrano‐Blanco, Juan Manuel Mendive Arbeloa, Victoria Garcia‐Cardenas, Alba Sánchez‐Viñas & Maria Rubio‐Valera. (2021) Non‐initiation of prescribed medication from a Spanish health professionals' perspective: A qualitative exploration based on Grounded Theory. Health & Social Care in the Community 30:1.
Crossref
Crossref
Shruti Goradia, Rachel Holland, Shea Alexander, Deborah Greenbaum, Timothy Chen & Parisa Aslani. (2021) A new age intervention to support medication adherence. Research in Social and Administrative Pharmacy 17:6, pages 1204-1207.
Crossref
Crossref
Muhammad Umair Khan & Parisa Aslani. (2020) Exploring factors influencing initiation, implementation and discontinuation of medications in adults with ADHD. Health Expectations 24:S1, pages 82-94.
Crossref
Crossref
Anas H. Khalifeh & Ayman M. Hamdan-Mansour. (2021) Prevalence, Barriers, and Interventions Related to Medication Adherence Among Patients With Major Depressive Disorder: A Scoping Review. Journal of Psychosocial Nursing and Mental Health Services 59:1, pages 39-51.
Crossref
Crossref
Bernardo Dell’Osso, Umberto Albert, Giuseppe Carrà, Maurizio Pompili, Maria Giulia Nanni, Massimo Pasquini, Nicola Poloni, Andrea Raballo, Fabio Sambataro, Gianluca Serafini, Caterina Viganò, Koen Demyttenaere, Roger S. McIntyre & Andrea Fiorillo. (2020) How to improve adherence to antidepressant treatments in patients with major depression: a psychoeducational consensus checklist. Annals of General Psychiatry 19:1.
Crossref
Crossref
Sara S. McMillan, Victoria Stewart, Amanda J. Wheeler, Fiona Kelly & Helen Stapleton. (2020) Medication management in the context of mental illness: an exploratory study of young people living in Australia. BMC Public Health 20:1.
Crossref
Crossref
Cristina Carbonell-Duacastella, M.ª Montserrat Gil-Girbau, M.ª Teresa Peñarrubia-María, Maria Rubio-Valera & Ignacio Aznar-Lou. (2020) Pacientes no iniciadores de tratamientos. FMC - Formación Médica Continuada en Atención Primaria 27:9, pages 476-479.
Crossref
Crossref
M. Gil-Girbau, I. Aznar-Lou, M.T. Peñarrubia-María, P. Moreno-Peral, A. Fernández, J.Á. Bellón, A.M. Jové, J. Mendive, R. Fernández-Vergel, A. Figueiras, M. March-Pujol & M. Rubio-Valera. (2020) Reasons for medication non-initiation: A qualitative exploration of the patients’ perspective. Research in Social and Administrative Pharmacy 16:5, pages 663-672.
Crossref
Crossref
Jennifer SevereJohn F. GredenPriyanka Reddy. (2020) Consequences of Recurrence of Major Depressive Disorder: Is Stopping Effective Antidepressant Medications Ever Safe?. FOCUS 18:2, pages 120-128.
Crossref
Crossref
L. Acheuk, C. Mouchoux, A. Lepetit & T. Novais. (2020) Représentations des pharmaciens et préparateurs en pharmacie vis-à-vis de la prise en soin de la dépression chez la personne âgée. Annales Pharmaceutiques Françaises 78:2, pages 167-178.
Crossref
Crossref
Muhammad Umair KhanParisa Aslani. (2019) A Review of Factors Influencing the Three Phases of Medication Adherence in People with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 29:6, pages 398-418.
Crossref
Crossref
Anna Wasik, Anna Krupa & Marcin Siwek. (2019) Interactions of antidepressants, mood-stabilisers and antipsychotics with food. Pharmacotherapy in Psychiatry and Neurology 35:1, pages 51-74.
Crossref
Crossref